Search

Your search keyword '"Burger, Charles D."' showing total 16 results
Start Over Author "Burger, Charles D." Publication Year Range Last 50 years Journal mayo clinic proceedings
16 results on '"Burger, Charles D."'

5. Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research

Author

O’Horo, John Charles, primary, Cerhan, James R., additional, Cahn, Elliot J., additional, Bauer, Philippe R., additional, Temesgen, Zelalem, additional, Ebbert, Jon, additional, Abril, Andy, additional, Abu Saleh, Omar M., additional, Assi, Mariam, additional, Berbari, Elie F., additional, Bierle, Dennis M., additional, Bosch, Wendelyn, additional, Burger, Charles D., additional, Cano Cevallos, Edison J., additional, Clements, Casey M., additional, Carmona Porquera, Eva M., additional, Castillo Almeida, Natalia E., additional, Challener, Douglas W., additional, Chesdachai, Supavit, additional, Comba, Isin Y., additional, Corsini Campioli, Cristina G., additional, Crane, Sarah J., additional, Dababneh, Ala S., additional, Enzler, Mark J., additional, Fadel, Hind J., additional, Ganesh, Ravindra, additional, De Moraes, Alice Gallo, additional, Go, John R., additional, Gordon, Joel E., additional, Gurram, Pooja R., additional, Guru, Pramod K., additional, Halverson, Erika L., additional, Harrison, Michael F., additional, Heaton, Heather A., additional, Hurt, Ryan, additional, Kasten, Mary J., additional, Lee, Augustine S., additional, Levy, Emily R., additional, Libertin, Claudia R., additional, Mallea, Jorge M., additional, Marshall, William F., additional, Matcha, Gautam, additional, Meehan, Anne M., additional, Franco, Pablo Moreno, additional, Morice, William G., additional, O’Brien, Jennifer J., additional, Oeckler, Richard, additional, Ommen, Steve, additional, Oravec, Caitlin P., additional, Orenstein, Robert, additional, Ough, Natalie J., additional, Palraj, Raj, additional, Patel, Bhavesh M., additional, Pureza, Vincent S., additional, Pickering, Brian, additional, Phelan, David M., additional, Razonable, Raymund R., additional, Rizza, Stacey, additional, Sampathkumar, Priya, additional, Sanghavi, Devang K., additional, Sen, Ayan, additional, Siegel, Jason L., additional, Singbartl, Kai, additional, Shah, Aditya S., additional, Shweta, FNU, additional, Speicher, Leigh L., additional, Suh, Gina, additional, Tabaja, Hussam, additional, Tande, Aaron, additional, Ting, Henry H., additional, Tontz, Russell C., additional, Vaillant, James J., additional, Vergidis, Paschalis, additional, Warsame, Mohamed Y., additional, Yetmar, Zachary A., additional, Zomok, Catherine (Cate) D., additional, Williams, Amy W., additional, and Badley, Andrew D., additional

Published
2021
Full Text
View/download PDF

6. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia

Author

Temesgen, Zelalem, primary, Assi, Mariam, additional, Shweta, F.N.U., additional, Vergidis, Paschalis, additional, Rizza, Stacey A., additional, Bauer, Philippe R., additional, Pickering, Brian W., additional, Razonable, Raymund R., additional, Libertin, Claudia R., additional, Burger, Charles D., additional, Orenstein, Robert, additional, Vargas, Hugo E., additional, Palraj, Raj, additional, Dababneh, Ala S., additional, Chappell, Gabrielle, additional, Chappell, Dale, additional, Ahmed, Omar, additional, Sakemura, Reona, additional, Durrant, Cameron, additional, Kenderian, Saad S., additional, and Badley, Andrew D., additional

Published
2020
Full Text
View/download PDF

16. Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research.

Author

O'Horo JC, Cerhan JR, Cahn EJ, Bauer PR, Temesgen Z, Ebbert J, Abril A, Abu Saleh OM, Assi M, Berbari EF, Bierle DM, Bosch W, Burger CD, Cano Cevallos EJ, Clements CM, Carmona Porquera EM, Castillo Almeida NE, Challener DW, Chesdachai S, Comba IY, Corsini Campioli CG, Crane SJ, Dababneh AS, Enzler MJ, Fadel HJ, Ganesh R, De Moraes AG, Go JR, Gordon JE, Gurram PR, Guru PK, Halverson EL, Harrison MF, Heaton HA, Hurt R, Kasten MJ, Lee AS, Levy ER, Libertin CR, Mallea JM, Marshall WF 3rd, Matcha G, Meehan AM, Franco PM, Morice WG 2nd, O'Brien JJ, Oeckler R, Ommen S, Oravec CP, Orenstein R, Ough NJ, Palraj R, Patel BM, Pureza VS, Pickering B, Phelan DM, Razonable RR, Rizza S, Sampathkumar P, Sanghavi DK, Sen A, Siegel JL, Singbartl K, Shah AS, Shweta F, Speicher LL, Suh G, Tabaja H Jr, Tande A, Ting HH, Tontz RC 3rd, Vaillant JJ, Vergidis P, Warsame MY, Yetmar ZA, Zomok CCD, Williams AW, and Badley AD

Subjects
Adolescent, COVID-19 epidemiology, Child, Child, Preschool, Female, Follow-Up Studies, Hospitalization trends, Humans, Infant, Infant, Newborn, Intensive Care Units statistics & numerical data, Male, Retrospective Studies, Biomedical Research, COVID-19 therapy, Pandemics, SARS-CoV-2
Abstract

Objective: To report the Mayo Clinic experience with coronavirus disease 2019 (COVID-19) related to patient outcomes., Methods: We conducted a retrospective chart review of patients with COVID-19 diagnosed between March 1, 2020, and July 31, 2020, at any of the Mayo Clinic sites. We abstracted pertinent comorbid conditions such as age, sex, body mass index, Charlson Comorbidity Index variables, and treatments received. Factors associated with hospitalization and mortality were assessed in univariate and multivariate models., Results: A total of 7891 patients with confirmed COVID-19 infection with research authorization on file received care across the Mayo Clinic sites during the study period. Of these, 7217 patients were adults 18 years or older who were analyzed further. A total of 897 (11.4%) patients required hospitalization, and 354 (4.9%) received care in the intensive care unit (ICU). All hospitalized patients were reviewed by a COVID-19 Treatment Review Panel, and 77.5% (695 of 897) of inpatients received a COVID-19-directed therapy. Overall mortality was 1.2% (94 of 7891), with 7.1% (64 of 897) mortality in hospitalized patients and 11.3% (40 of 354) in patients requiring ICU care., Conclusion: Mayo Clinic outcomes of patients with COVID-19 infection in the ICU, hospital, and community compare favorably with those reported nationally. This likely reflects the impact of interprofessional multidisciplinary team evaluation, effective leveraging of clinical trials and available treatments, deployment of remote monitoring tools, and maintenance of adequate operating capacity to not require surge adjustments. These best practices can help guide other health care systems with the continuing response to the COVID-19 pandemic., (Copyright © 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results